Sherri Candelario

Sherri Candelario, Ph.D. has more than 20 years’ experience in biotechnology startup companies. As a patent agent and pharmacologist, she works with scientists in the company to help determine the patentability of new innovations. She has unique expertise in defining which inventions will lead to a patent that will be a viable commercial product.

Dr. Candelario worked with Indi Molecular’s founding scientists from Cal Tech to create the company’s patent portfolio. She developed IP strategies for the earliest PCC foundational patents through the current radiotherapeutic products.

Earlier in her career, Dr. Candelario developed the patent strategy for several companies that have merged or become public, including Ikaria, Inc., Nanostring Technologies, and Integrated Diagnostics. She has expertise in not-for-profit science enterprises and served as Intellectual Property Director of Institute for Systems Biology for several years.

Dr. Candelario led the business side of intellectual property negotiations for several rounds of venture funding for multiple companies. She has expertise in intellectual property acquisitions by public companies and has successfully worked with legal teams to transfer the patent portfolios she developed to four public companies. Dr. Candelario has also negotiated license agreements with major companies, hospitals, and universities.